ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nucleic Acid Medicine Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-39L12686
Home | Market Reports | Science| Biological Sciences
Global Nucleic Acid Medicine Market Research Report 2022
BUY CHAPTERS

Global Nucleic Acid Medicine Market Research Report 2025

Code: QYRE-Auto-39L12686
Report
February 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Ionis
Nippon Shinyaku
Alnylam
Sarepta Therapeutics
Mina Therapeutics
BioNTech
Moderna, Inc

Nucleic Acid Medicine Market Size

The global market for Nucleic Acid Medicine was valued at US$ 84.3 million in the year 2024 and is projected to reach a revised size of US$ 138 million by 2031, growing at a CAGR of 7.4% during the forecast period.

Nucleic Acid Medicine Market

Nucleic Acid Medicine Market

Nucleic acid medicines utilize nucleic acid, which refer to substances such as DNA and RNA that control genetic information, as drugs. These allow targeting of molecules such as mRNA and miRNA that cannot be targeted with traditional low molecular weight drugs and antibody medicines, and there is a great expectation for these drugs as next generation pharmaceuticals. Active research is being conducted globally as it is expected to lead to the creation of drugs which were previously intractable.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Nucleic acid medicines, as innovative products in the field of biomedicine, are gradually demonstrating significant global potential. The market size is expanding, with sales steadily increasing. These medicines have specific uses in various areas such as oncology, genetic disorders, and vaccine development, offering novel possibilities for precision medicine and personalized treatment due to their unique molecular characteristics. In the future, with technological advancements and deeper clinical research, nucleic acid medicines are expected to be continuously optimized, expanding their applications to a wider range of disease areas, thus bringing about more revolutionary breakthroughs in the field of healthcare.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Medicine.
The Nucleic Acid Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nucleic Acid Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic Acid Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Nucleic Acid Medicine Market Report

Report Metric Details
Report Name Nucleic Acid Medicine Market
Accounted market size in year US$ 84.3 million
Forecasted market size in 2031 US$ 138 million
CAGR 7.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Ionis, Nippon Shinyaku, Alnylam, Sarepta Therapeutics, MiNA Therapeutics, BioNTech, Moderna
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Nucleic Acid Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Nucleic Acid Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Nucleic Acid Medicine Market growing?

Ans: The Nucleic Acid Medicine Market witnessing a CAGR of 7.4% during the forecast period 2025-2031.

What is the Nucleic Acid Medicine Market size in 2031?

Ans: The Nucleic Acid Medicine Market size in 2031 will be US$ 138 million.

Who are the main players in the Nucleic Acid Medicine Market report?

Ans: The main players in the Nucleic Acid Medicine Market are Novartis, Ionis, Nippon Shinyaku, Alnylam, Sarepta Therapeutics, MiNA Therapeutics, BioNTech, Moderna

What are the Application segmentation covered in the Nucleic Acid Medicine Market report?

Ans: The Applications covered in the Nucleic Acid Medicine Market report are Cardiovascular Diseases, Hepatitis B, Hypertension, Other

What are the Type segmentation covered in the Nucleic Acid Medicine Market report?

Ans: The Types covered in the Nucleic Acid Medicine Market report are ASO, siRNA, Other

Recommended Reports

Gene and Nucleic Acid Therapies

Pharmaceutical and Drug Markets

Oncology and Disease Treatment

1 Nucleic Acid Medicine Market Overview
1.1 Product Definition
1.2 Nucleic Acid Medicine by Type
1.2.1 Global Nucleic Acid Medicine Market Value Comparison by Type (2024 VS 2031)
1.2.2 ASO
1.2.3 siRNA
1.2.4 Other
1.3 Nucleic Acid Medicine by Application
1.3.1 Global Nucleic Acid Medicine Market Value by Application (2024 VS 2031)
1.3.2 Cardiovascular Diseases
1.3.3 Hepatitis B
1.3.4 Hypertension
1.3.5 Other
1.4 Global Nucleic Acid Medicine Market Size Estimates and Forecasts
1.4.1 Global Nucleic Acid Medicine Revenue 2020-2031
1.4.2 Global Nucleic Acid Medicine Sales 2020-2031
1.4.3 Global Nucleic Acid Medicine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Nucleic Acid Medicine Market Competition by Manufacturers
2.1 Global Nucleic Acid Medicine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Nucleic Acid Medicine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Nucleic Acid Medicine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Nucleic Acid Medicine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nucleic Acid Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nucleic Acid Medicine, Product Type & Application
2.7 Global Key Manufacturers of Nucleic Acid Medicine, Date of Enter into This Industry
2.8 Global Nucleic Acid Medicine Market Competitive Situation and Trends
2.8.1 Global Nucleic Acid Medicine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nucleic Acid Medicine Players Market Share by Revenue
2.8.3 Global Nucleic Acid Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nucleic Acid Medicine Market Scenario by Region
3.1 Global Nucleic Acid Medicine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Nucleic Acid Medicine Sales by Region: 2020-2031
3.2.1 Global Nucleic Acid Medicine Sales by Region: 2020-2025
3.2.2 Global Nucleic Acid Medicine Sales by Region: 2026-2031
3.3 Global Nucleic Acid Medicine Revenue by Region: 2020-2031
3.3.1 Global Nucleic Acid Medicine Revenue by Region: 2020-2025
3.3.2 Global Nucleic Acid Medicine Revenue by Region: 2026-2031
3.4 North America Nucleic Acid Medicine Market Facts & Figures by Country
3.4.1 North America Nucleic Acid Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Nucleic Acid Medicine Sales by Country (2020-2031)
3.4.3 North America Nucleic Acid Medicine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nucleic Acid Medicine Market Facts & Figures by Country
3.5.1 Europe Nucleic Acid Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Nucleic Acid Medicine Sales by Country (2020-2031)
3.5.3 Europe Nucleic Acid Medicine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nucleic Acid Medicine Market Facts & Figures by Region
3.6.1 Asia Pacific Nucleic Acid Medicine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Nucleic Acid Medicine Sales by Region (2020-2031)
3.6.3 Asia Pacific Nucleic Acid Medicine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nucleic Acid Medicine Market Facts & Figures by Country
3.7.1 Latin America Nucleic Acid Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Nucleic Acid Medicine Sales by Country (2020-2031)
3.7.3 Latin America Nucleic Acid Medicine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nucleic Acid Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Nucleic Acid Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Nucleic Acid Medicine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Nucleic Acid Medicine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nucleic Acid Medicine Sales by Type (2020-2031)
4.1.1 Global Nucleic Acid Medicine Sales by Type (2020-2025)
4.1.2 Global Nucleic Acid Medicine Sales by Type (2026-2031)
4.1.3 Global Nucleic Acid Medicine Sales Market Share by Type (2020-2031)
4.2 Global Nucleic Acid Medicine Revenue by Type (2020-2031)
4.2.1 Global Nucleic Acid Medicine Revenue by Type (2020-2025)
4.2.2 Global Nucleic Acid Medicine Revenue by Type (2026-2031)
4.2.3 Global Nucleic Acid Medicine Revenue Market Share by Type (2020-2031)
4.3 Global Nucleic Acid Medicine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Nucleic Acid Medicine Sales by Application (2020-2031)
5.1.1 Global Nucleic Acid Medicine Sales by Application (2020-2025)
5.1.2 Global Nucleic Acid Medicine Sales by Application (2026-2031)
5.1.3 Global Nucleic Acid Medicine Sales Market Share by Application (2020-2031)
5.2 Global Nucleic Acid Medicine Revenue by Application (2020-2031)
5.2.1 Global Nucleic Acid Medicine Revenue by Application (2020-2025)
5.2.2 Global Nucleic Acid Medicine Revenue by Application (2026-2031)
5.2.3 Global Nucleic Acid Medicine Revenue Market Share by Application (2020-2031)
5.3 Global Nucleic Acid Medicine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Nucleic Acid Medicine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Nucleic Acid Medicine Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Ionis
6.2.1 Ionis Company Information
6.2.2 Ionis Description and Business Overview
6.2.3 Ionis Nucleic Acid Medicine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Ionis Nucleic Acid Medicine Product Portfolio
6.2.5 Ionis Recent Developments/Updates
6.3 Nippon Shinyaku
6.3.1 Nippon Shinyaku Company Information
6.3.2 Nippon Shinyaku Description and Business Overview
6.3.3 Nippon Shinyaku Nucleic Acid Medicine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Nippon Shinyaku Nucleic Acid Medicine Product Portfolio
6.3.5 Nippon Shinyaku Recent Developments/Updates
6.4 Alnylam
6.4.1 Alnylam Company Information
6.4.2 Alnylam Description and Business Overview
6.4.3 Alnylam Nucleic Acid Medicine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Alnylam Nucleic Acid Medicine Product Portfolio
6.4.5 Alnylam Recent Developments/Updates
6.5 Sarepta Therapeutics
6.5.1 Sarepta Therapeutics Company Information
6.5.2 Sarepta Therapeutics Description and Business Overview
6.5.3 Sarepta Therapeutics Nucleic Acid Medicine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sarepta Therapeutics Nucleic Acid Medicine Product Portfolio
6.5.5 Sarepta Therapeutics Recent Developments/Updates
6.6 MiNA Therapeutics
6.6.1 MiNA Therapeutics Company Information
6.6.2 MiNA Therapeutics Description and Business Overview
6.6.3 MiNA Therapeutics Nucleic Acid Medicine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 MiNA Therapeutics Nucleic Acid Medicine Product Portfolio
6.6.5 MiNA Therapeutics Recent Developments/Updates
6.7 BioNTech
6.7.1 BioNTech Company Information
6.7.2 BioNTech Description and Business Overview
6.7.3 BioNTech Nucleic Acid Medicine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 BioNTech Nucleic Acid Medicine Product Portfolio
6.7.5 BioNTech Recent Developments/Updates
6.8 Moderna
6.8.1 Moderna Company Information
6.8.2 Moderna Description and Business Overview
6.8.3 Moderna Nucleic Acid Medicine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Moderna Nucleic Acid Medicine Product Portfolio
6.8.5 Moderna Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nucleic Acid Medicine Industry Chain Analysis
7.2 Nucleic Acid Medicine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nucleic Acid Medicine Production Mode & Process Analysis
7.4 Nucleic Acid Medicine Sales and Marketing
7.4.1 Nucleic Acid Medicine Sales Channels
7.4.2 Nucleic Acid Medicine Distributors
7.5 Nucleic Acid Medicine Customer Analysis
8 Nucleic Acid Medicine Market Dynamics
8.1 Nucleic Acid Medicine Industry Trends
8.2 Nucleic Acid Medicine Market Drivers
8.3 Nucleic Acid Medicine Market Challenges
8.4 Nucleic Acid Medicine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
Ionis
Nippon Shinyaku
Alnylam
Sarepta Therapeutics
Mina Therapeutics
BioNTech
Moderna, Inc
List of Tables
 Table 1. Global Nucleic Acid Medicine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Nucleic Acid Medicine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Nucleic Acid Medicine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Nucleic Acid Medicine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Nucleic Acid Medicine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Nucleic Acid Medicine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Nucleic Acid Medicine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Nucleic Acid Medicine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Nucleic Acid Medicine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Nucleic Acid Medicine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Nucleic Acid Medicine, Product Type & Application
 Table 12. Global Key Manufacturers of Nucleic Acid Medicine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Nucleic Acid Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Medicine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Nucleic Acid Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Nucleic Acid Medicine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Nucleic Acid Medicine Sales Market Share by Region (2020-2025)
 Table 19. Global Nucleic Acid Medicine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Nucleic Acid Medicine Sales Market Share by Region (2026-2031)
 Table 21. Global Nucleic Acid Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Nucleic Acid Medicine Revenue Market Share by Region (2020-2025)
 Table 23. Global Nucleic Acid Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Nucleic Acid Medicine Revenue Market Share by Region (2026-2031)
 Table 25. North America Nucleic Acid Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Nucleic Acid Medicine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Nucleic Acid Medicine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Nucleic Acid Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Nucleic Acid Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Nucleic Acid Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Nucleic Acid Medicine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Nucleic Acid Medicine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Nucleic Acid Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Nucleic Acid Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Nucleic Acid Medicine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Nucleic Acid Medicine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Nucleic Acid Medicine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Nucleic Acid Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Nucleic Acid Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Nucleic Acid Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Nucleic Acid Medicine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Nucleic Acid Medicine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Nucleic Acid Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Nucleic Acid Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Nucleic Acid Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Nucleic Acid Medicine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Nucleic Acid Medicine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Nucleic Acid Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Nucleic Acid Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Nucleic Acid Medicine Sales (K Units) by Type (2020-2025)
 Table 51. Global Nucleic Acid Medicine Sales (K Units) by Type (2026-2031)
 Table 52. Global Nucleic Acid Medicine Sales Market Share by Type (2020-2025)
 Table 53. Global Nucleic Acid Medicine Sales Market Share by Type (2026-2031)
 Table 54. Global Nucleic Acid Medicine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Nucleic Acid Medicine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Nucleic Acid Medicine Revenue Market Share by Type (2020-2025)
 Table 57. Global Nucleic Acid Medicine Revenue Market Share by Type (2026-2031)
 Table 58. Global Nucleic Acid Medicine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Nucleic Acid Medicine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Nucleic Acid Medicine Sales (K Units) by Application (2020-2025)
 Table 61. Global Nucleic Acid Medicine Sales (K Units) by Application (2026-2031)
 Table 62. Global Nucleic Acid Medicine Sales Market Share by Application (2020-2025)
 Table 63. Global Nucleic Acid Medicine Sales Market Share by Application (2026-2031)
 Table 64. Global Nucleic Acid Medicine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Nucleic Acid Medicine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Nucleic Acid Medicine Revenue Market Share by Application (2020-2025)
 Table 67. Global Nucleic Acid Medicine Revenue Market Share by Application (2026-2031)
 Table 68. Global Nucleic Acid Medicine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Nucleic Acid Medicine Price (US$/Unit) by Application (2026-2031)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis Nucleic Acid Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novartis Nucleic Acid Medicine Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. Ionis Company Information
 Table 76. Ionis Description and Business Overview
 Table 77. Ionis Nucleic Acid Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Ionis Nucleic Acid Medicine Product
 Table 79. Ionis Recent Developments/Updates
 Table 80. Nippon Shinyaku Company Information
 Table 81. Nippon Shinyaku Description and Business Overview
 Table 82. Nippon Shinyaku Nucleic Acid Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Nippon Shinyaku Nucleic Acid Medicine Product
 Table 84. Nippon Shinyaku Recent Developments/Updates
 Table 85. Alnylam Company Information
 Table 86. Alnylam Description and Business Overview
 Table 87. Alnylam Nucleic Acid Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Alnylam Nucleic Acid Medicine Product
 Table 89. Alnylam Recent Developments/Updates
 Table 90. Sarepta Therapeutics Company Information
 Table 91. Sarepta Therapeutics Description and Business Overview
 Table 92. Sarepta Therapeutics Nucleic Acid Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Sarepta Therapeutics Nucleic Acid Medicine Product
 Table 94. Sarepta Therapeutics Recent Developments/Updates
 Table 95. MiNA Therapeutics Company Information
 Table 96. MiNA Therapeutics Description and Business Overview
 Table 97. MiNA Therapeutics Nucleic Acid Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. MiNA Therapeutics Nucleic Acid Medicine Product
 Table 99. MiNA Therapeutics Recent Developments/Updates
 Table 100. BioNTech Company Information
 Table 101. BioNTech Description and Business Overview
 Table 102. BioNTech Nucleic Acid Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. BioNTech Nucleic Acid Medicine Product
 Table 104. BioNTech Recent Developments/Updates
 Table 105. Moderna Company Information
 Table 106. Moderna Description and Business Overview
 Table 107. Moderna Nucleic Acid Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Moderna Nucleic Acid Medicine Product
 Table 109. Moderna Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Nucleic Acid Medicine Distributors List
 Table 113. Nucleic Acid Medicine Customers List
 Table 114. Nucleic Acid Medicine Market Trends
 Table 115. Nucleic Acid Medicine Market Drivers
 Table 116. Nucleic Acid Medicine Market Challenges
 Table 117. Nucleic Acid Medicine Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Nucleic Acid Medicine
 Figure 2. Global Nucleic Acid Medicine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Nucleic Acid Medicine Market Share by Type: 2024 & 2031
 Figure 4. ASO Product Picture
 Figure 5. siRNA Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Nucleic Acid Medicine Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Nucleic Acid Medicine Market Share by Application: 2024 & 2031
 Figure 9. Cardiovascular Diseases
 Figure 10. Hepatitis B
 Figure 11. Hypertension
 Figure 12. Other
 Figure 13. Global Nucleic Acid Medicine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Nucleic Acid Medicine Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Nucleic Acid Medicine Sales (2020-2031) & (K Units)
 Figure 16. Global Nucleic Acid Medicine Average Price (US$/Unit) & (2020-2031)
 Figure 17. Nucleic Acid Medicine Report Years Considered
 Figure 18. Nucleic Acid Medicine Sales Share by Manufacturers in 2024
 Figure 19. Global Nucleic Acid Medicine Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Nucleic Acid Medicine Players: Market Share by Revenue in Nucleic Acid Medicine in 2024
 Figure 21. Nucleic Acid Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Nucleic Acid Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Nucleic Acid Medicine Sales Market Share by Country (2020-2031)
 Figure 24. North America Nucleic Acid Medicine Revenue Market Share by Country (2020-2031)
 Figure 25. United States Nucleic Acid Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Nucleic Acid Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Nucleic Acid Medicine Sales Market Share by Country (2020-2031)
 Figure 28. Europe Nucleic Acid Medicine Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Nucleic Acid Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Nucleic Acid Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Nucleic Acid Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Nucleic Acid Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Nucleic Acid Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Nucleic Acid Medicine Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Nucleic Acid Medicine Revenue Market Share by Region (2020-2031)
 Figure 36. China Nucleic Acid Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Nucleic Acid Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Nucleic Acid Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Nucleic Acid Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Nucleic Acid Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Nucleic Acid Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Nucleic Acid Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Nucleic Acid Medicine Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Nucleic Acid Medicine Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Nucleic Acid Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Nucleic Acid Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Nucleic Acid Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Nucleic Acid Medicine Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Nucleic Acid Medicine Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Nucleic Acid Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Nucleic Acid Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Nucleic Acid Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Nucleic Acid Medicine by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Nucleic Acid Medicine by Type (2020-2031)
 Figure 55. Global Nucleic Acid Medicine Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Nucleic Acid Medicine by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Nucleic Acid Medicine by Application (2020-2031)
 Figure 58. Global Nucleic Acid Medicine Price (US$/Unit) by Application (2020-2031)
 Figure 59. Nucleic Acid Medicine Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Nucleic Acid Drugs Market Research Report 2025
Global Low Molecular Weight Nucleic Acid Drugs Market Research Report 2025
Global RNA based Therapeutics Drug Market Research Report 2024
Global Nucleic Acid Therapeutic Market Research Report 2024
Global Nucleic acid based Therapeutics Drug Market Research Report 2024
Global Nucleic Acid based Therapy Market Research Report 2024
Global Nucleic Acid Drug Raw Materials Market Research Report 2025
Global Oligonucleotide Drugs ONs Market Research Report 2025
Global Small Nucleic Acid Drug Market Research Report 2025
Global Nucleic Acid based Drugs Market Research Report 2024
Global Nucleic Acid Vaccine Market Insights Forecast to 2030
Global Small Nucleic Acid Based Drug Market Research Report 2025
Global RNA Therapeutics Market Research Report 2024
Global Oligonucleotide Oligo Drugs Market Research Report 2024
Small Molecule Nucleic Acid Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antisense and RNAi Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nucleic Acid Based Gene Therapy Market Research Report 2025
Global Nucleic Acid Based Gene Therapeutics Market Research Report 2024
Oligonucleotide Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Small Interfering RNA siRNA Drugs Market Research Report 2024

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6C20013
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K19803
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions